China’s approval of 5 GMO crop imports could fuel investment boom in biotech research

trade war
Image Credit: Gapping World

Lost in the news of contentious U.S.-China trade disputes was a meaningful regulatory approval that will improve agriculture around the world.

[In January] Chinese regulators approved the import of five genetically modified crops. These soybean, corn and canola “biotech traits” are designed to grow despite natural obstacles like pest infestation….

This little-noticed agreement will have a big impact on the U.S. agriculture industry. China has accounted for about 60% of total U.S. soy exports, representing $12 billion in trade for American farmers. Those figures may grow; the newly-approved crops will be in high demand.

The agricultural industry must increase investments in biotechnology. New soil-management, crop-protection and seed-enhancement techniques—which promise to make plants more resistant to drought, disease and pests—sometimes take hundreds of millions of dollars to develop and decades to bring to market. The newly-open Chinese market will reward such innovation.

Any global regulatory system that reviews and ultimately approves these technologies must be science-based. GMO regulatory processes have historically been plagued by politicized disputes which needlessly delay the sale of these vital crops. Hopefully the new agreement with China is a sign that chapter has passed.

Read full, original article: China Opens the Door to U.S. GMOs

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-30-2026-01_09_47-PM
Viewpoint: As MAHA blows up over Supreme Court ruling limiting glyphosate litigation, Trump offers toothless plan to reduce pesticides in food
ChatGPT-Image-Jun-23-2026-12_19_35-PM
Ideological red flag: Led by anti-vax doctor, Tennessee is now the U.S. epicenter selling potent ivermectin shown worthless to prevent or treat Covid
Screenshot-2026-06-30-at-2.06.25-PM
PEW study: The sick state of American health information
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Screenshot-2026-06-30-at-3.08.03-PM
From infrared sauna blankets to collagen gummies, here’s the top 10 social-media-promoted wellness shams
Screenshot-2026-06-30-at-10.43.50-AM
Viewpoint: Why are there no approved bioengineered insect-protected (Bt) apples?
photodune farming tractor s
Viewpoint: Glyphosate may be hazardous, but it is not dangerous as used by farmers. Critics of the Supreme Court’s Roundup ruling garble hazard with risk
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
marijuana-pot-in-hand-nveri-st-xpm-t-abq-fkifeos-s-rws-cmpx-
Facts & Fallacies podcast: Legalized weed drives drug addiction, psychosis?
ChatGPT-Image-Mar-4-2026-09_39_03-AM
Transgender female athletes and Title IX: Separating ‘policy’ from ‘legality’
ChatGPT-Image-Jun-30-2026-02_48_10-PM
Independent news review site launches free credibility and fact-vetted aggregation chatbot
ChatGPT-Image-Jun-25-2026-01_14_50-PM
Viewpoint: Disinformation grift: The wellness industry is a lucrative and mostly worthless marketplace of ‘balms, brews, and baloney’
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.